Executives inside pharmaceutical giant AstraZeneca faced a high-stakes dilemma.
On one hand, Chicago psychiatrist Dr. Michael Reinstein was bringing the company a small fortune in sales and was conducting research that made one of its most promising drugs look spectacular.
On the other, some worried that his research findings might be too good to be true.
Recent comments
4 days 1 hour ago
4 days 21 hours ago
5 days 7 hours ago
6 days 18 hours ago
1 week 2 days ago
1 week 5 days ago
1 week 6 days ago
2 weeks 19 hours ago
2 weeks 3 days ago
2 weeks 5 days ago